logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mario Mancino

medica scientia innovation research
H指数:23
被引数:3,727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial

HER2阳性早期乳腺癌化疗降级治疗的5年结局及PHERGain随机II期试验中的探索性循环肿瘤DNA分析

Nature Medicine
IF50
2026-10-290
OAAI
José Manuel Pérez-García; Javier Cortés; Manuel Ruiz-Borrego; Agostina Stradella; Begoña Bermejo; Santiago Escrivá-de-Romaní; Cristina Reboredo; Cinta Albacar; Noelia Martínez-Jáñez; Vega Iranzo; Nuria Ribelles; Florence Dalenc; Aleix Prat; Peter Schmid; Geraldine Gebhart; Frederik Marmé; Serena Di Cosimo; Sofia Braga; Marco Colleoni; Gabriele Antonarelli; Giulia Notini; Maria Gion; Juan José García-Mosquera; Lucia Sanz; Elena Martinez-Garcia; Alba Meya; Derek Dustin; Ana Amaya-Garrido; Jose Antonio Guerrero-Martínez; Daniel Alcalá-López; Jose Rodríguez-Morató; Leonardo Mina; Mario Mancino; Antonio Llombart-Cussac
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial

帕他单抗德鲁克替康（HER3-DXd）在活动性脑转移的非小细胞肺癌患者中的应用（TUXEDO-3）：一项多中心、单臂、II期临床试验

The Lancet Oncology
IF0
2025-10-270
PRE
Thorsten Fuereder; Javier Garde-Noguera; Juan José García-Mosquera; Manuel Ruiz-Borrego; María Valero; Antonio Llombart-Cussac; María Gion; Richard Greil; Miriam Arumi; Marta Campolier; José Antonio Guerrero; Giulia Raimondi; Mario Mancino; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Maximilian Marhold; Anna Sophie Berghoff; Julia Furtner; Rupert Bartsch; Matthias Preusser
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

HER2DX和早期HER2阳性乳腺癌的生存结局：一项基于个体患者水平的荟萃分析

lancet oncology
IF0
2025-07-140
PRE
Guillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney
Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial

来自PARSIFAL试验的激素受体阳性晚期乳腺癌中palbociclib反应的生物标志物

npj Breast Cancer
IF7.6
2025-06-200
OAAI
Joan Albanell; Angelo Gámez Pozo; Carlos L. Arteaga; Meritxell Bellet; Federico Rojo; Abel González; Beatriz Bellosillo; Violeta Serra; Petra Gener; José Antonio Guerrero; Eileen Shimizu; Mario Mancino; Jose Rodríguez-Morató; Leonardo Mina; José Manuel Pérez-García; Javier Cortés; Antonio Llombart-Cussac
ctDNA-based DNADX in hormone receptorpositive and HER2-negative (HR+/HER2-) advanced breast cancer following endocrine therapy and CDK4/6 inhibition: a correlative analysis from the randomized phase 2 PARSIFAL trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Braso-Maristany, Fara; Cortes, Javier; Perez-Garcia, Jose Manuel; Vega-Leon, Rosario; Pare, Laia; Villacampa, Guillermo; Matito, Judit; Pardo, Francisco; Gomez-Rey, Marina; Mancino, Mario; Martinez-Garcia, Elena; Gallardo, Carmen Mora; Mina, Leonardo; Dalenc, Florence; Bellet-Ezquerra, Meritxell; Ruiz-Borrego, Manuel; Gil-Gil, Miguel; Schmid, Peter; Perou, Charles M.; Parker, Joel S.; Villagrasa, Patricia; Vivancos, Ana; Prat, Aleix; Llombart-Cussac, Antonio
MiRaDor: A proof-of- concept study of treatment efficacy by monitoring Minimal Residual Disease (MRD) using circulating tumor DNA (ctDNA) in hormone receptor-positive/HER2-negative (HR+/HER2-) early breast cancer (EBC)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Llombart-Cussac, Antonio; Perez-Garcia, Jose Manuel; Gion, Maria; Alcala-Lopez, Daniel; Fazal-Salom, Janet; Lazaris, Alexandros; Mancino, Mario; Shimizu, Eileen; Victorino, Susana; Zhang, Rui Rui; Machackova, Zuzana; Schimmoller, Frauke; Wongchenko, Matthew; Gligorov, Joseph; Schmid, Peter; Cortes, Javier
Evaluation of HER2DX risk-score in residual disease (RD) from HER2-positive (HER2+) early breast cancer (EBC) patients (pts) following neoadjuvant trastuzumab and pertuzumab (HP)-based therapy: An exploratory analysis from the PHERGain trial
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Perez-Garcia, Jose Manuel; Braso-Maristany, Fara; Martinez-Garcia, Elena; Gallardo, Carmen Mora; Shimizu, Eileen; Sanchez, Olga Boix; Rodriguez-Morato, Jose; Mancino, Mario; Pare, Laia; Villacampa, Guillermo; Marin-Aguilera, Mercedes; Galvan, Patricia; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel; Perou, Charles M.; Llombart-Cussac, Antonio; Cortes, Javier; Prat, Aleix
Prospective evaluation of predictive biomarkers for Palbociclib (P) and endocrine therapy (ET) benefit in hormone receptor (HR)-positive [ plus ]/human epidermal growth factor receptor 2 (HER2)-negative [-] advanced breast cancer (ABC) patients (pts) from PARSIFAL clinical trial: The transFAL sub-study
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Albanell, Joan; Pozo, Angelo Gamez; Arteaga, Carlos L.; Bellet, Meritxell; Rojo, Federico; Gonzalez, Abel; Bellosillo, Beatriz; Serra, Violeta; Gener, Petra; Guerrero, Jose Antonio; Lopez-Montero, Laura; Mancino, Mario; Rodriguez-Morato, Jose; Mina, Leonardo; Perez-Garcia, Jose Manuel; Cortes, Javier; Llombart-Cussac, Antonio
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-03-082
OA
Gion, Maria; Jose Garcia-Mosquera, Juan; Manuel Perez-Garcia, Jose; Peg, Vicente; Ruiz-Borrego, Manuel; Stradella, Agostina; Bermejo, Begona; Antonio Guerrero, Jose; Lopez-Montero, Laura; Mancino, Mario; Rodriguez-Morato, Jose; Antonarelli, Gabriele; Sampayo-Cordero, Miguel; Llombart-Cussac, Antonio; Cortes, Javier
Validation of a genomic assay in early-stage HER2+breast cancer (BC) treated with trastuzumab and pertuzumab (HP): A correlative analysis from PHERGain phase II trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
PRE
Llombart Cussac, A.; Perez-Garcia, J. M.; Pare Brunet, L.; Villacampa Javierre, G.; Braso-Maristany, F.; Gion Cortes, M.; Schmid, P.; Colleoni, M. A.; Ruiz Borrego, M.; Galvan, P.; Parker, J.; Perou, C. M.; Villagrasa Gonzalez, P.; Guerrero, J. A.; Sampayo-Cordero, M.; Mancino, M.; Prat, A.; Cortes, J.
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
EMBO MOLECULAR MEDICINE
IF8.3
2021-08-116
OAAI
Herranz, Carmen; Mateo, Francesca; Baiges, Alexandra; de Garibay, Gorka Ruiz; Junza, Alexandra; Johnson, Simon R.; Miller, Suzanne; Garcia, Nadia; Capellades, Jordi; Gomez, Antonio; Vidal, August; Palomero, Luis; Espin, Roderic; Extremera, Ana, I; Blommaert, Eline; Revilla-Lopez, Eva; Saez, Berta; Gomez-Olles, Susana; Ancochea, Julio; Valenzuela, Claudia; Alonso, Tamara; Ussetti, Piedad; Laporta, Rosalia; Xaubet, Antoni; Rodriguez-Portal, Jose A.; Montes-Worboys, Ana; Machahua, Carlos; Bordas, Jaume; Menendez, Javier A.; Cruzado, Josep M.; Guiteras, Roser; Bontoux, Christophe; La Motta, Concettina; Noguera-Castells, Aleix; Mancino, Mario; Lastra, Enrique; Rigo-Bonnin, Raul; Perales, Jose C.; Vinals, Francesc; Lahiguera, Alvaro; Zhang, Xiaohu; Cuadras, Daniel; van Moorsel, Coline H. M.; van der Vis, Joanne J.; Quanjel, Marian J. R.; Filippakis, Harilaos; Hakem, Razq; Gorrini, Chiara; Ferrer, Marc; Ugun-Klusek, Aslihan; Billett, Ellen; Radzikowska, Elzbieta; Casanova, Alvaro; Molina-Molina, Maria; Roman, Antonio; Yanes, Oscar; Pujana, Miquel A.
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
CLINICAL CANCER RESEARCH
IF10.2
2020-03-1363
OAAI
Fernandez-Nogueira, Patricia; Mancino, Mario; Fuster, Gemma; Lopez-Plana, Anna; Jauregui, Patricia; Almendro, Vanesa; Enreig, Estel; Menendez, Silvia; Rojo, Federico; Noguera-Castells, Aleix; Bill, Anke; Gaither, L. Alex; Serrano, Laia; Recalde-Percaz, Leire; Moragas, Nuria; Alonso, Raul; Ametller, Elisabet; Rovira, Ana; Lluch, Ana; Albanell, Joan; Gascon, Pere; Bragado, Paloma
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2020-02-0622
OAAI
Lopez-Plana, Anna; Fernandez-Nogueira, Patricia; Munoz-Guardiola, Pau; Sole-Sanchez, Sonia; Megias-Roda, Elisabet; Perez-Montoyo, Hector; Jauregui, Patricia; Yeste-Velasco, Marc; Gomez-Ferreria, Mariana; Erazo, Tatiana; Ametller, Elisabet; Recalde-Percaz, Leire; Moragas-Garcia, Nuria; Noguera-Castells, Aleix; Mancino, Mario; Moran, Teresa; Nadal, Ernest; Alfon, Jose; Domenech, Carles; Gascon, Pere; Lizcano, Jose M.; Fuster, Gemma; Bragado, Paloma
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
BREAST CANCER RESEARCH
IF5.6
2018-07-0412
OAAI
Zubeldia-Plazaola, Arantzazu; Recalde-Percaz, Leire; Moragas, Nuria; Alcaraz, Mireia; Chen, Xieng; Mancino, Mario; Fernandez-Nogueira, Patricia; Prats de Puig, Miquel; Guzman, Flavia; Noguera-Castells, Aleix; Lopez-Plana, Anna; Enreig, Estel; Carbo, Neus; Almendro, Vanessa; Gascon, Pedro; Bragado, Paloma; Fuster, Gemma

研究方向

暂未获取到该数据
G
Gemma Fuster
H 指数:24论文数:110被引数:2,131
P
Patricia Fernández‐Nogueira
H 指数:13论文数:68被引数:691
A
Antonio Llombart‐Cussac
H 指数:59论文数:698被引数:1.6万
J
Javier Cortés
H 指数:113论文数:1,481被引数:6.8万
P
Paloma Bragado
H 指数:26论文数:145被引数:4,437
E
Elisabet Ametller
H 指数:20论文数:63被引数:1,602
J
José Manuel Pérez-García
H 指数:35论文数:252被引数:7,084
P
Pedro Gascón
H 指数:35论文数:149被引数:4,026
P
Pere Gascón
H 指数:47论文数:411被引数:1.3万
E
Estel Enreig
H 指数:3论文数:38被引数:197